Dumayaca, Arwin .
HRN: 23-70-04 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/16/2024
11/23/2024
IV
1.5g
Q8h
Diabetic Foot Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes